Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Withdrawn 1Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 31Melanoma 20Neoplasms 13Breast Neoplasms 11Stomach Neoplasms 9Pancreatic Neoplasms 9Neoplasm Metastasis 9Lung Neoplasms 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Colorectal Neoplasms 7Carcinoma, Renal Cell 7Carcinoma, Hepatocellular 6Prostatic Neoplasms 4Hodgkin Disease 4Glioblastoma 4Carcinoma, Transitional Cell 4Carcinoma 4Uterine Cervical Neoplasms 3Liver Neoplasms 3Kidney Neoplasms 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Adenocarcinoma 3Small Cell Lung Carcinoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms, Squamous Cell 2Mesothelioma 2

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Clear-cell metastatic renal cell carcinoma × pembrolizumab × Clear all
NCT05567588 2024-02-01

Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer

Nanfang Hospital, Southern Medical University

Phase 2 Unknown
66 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡